ArticleMolecular oncology2026

Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy.

Andreas Ullern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.